Literature DB >> 4479779

Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: the pharmacokinetics of loperamide in rats and man.

J Heykants, M Michiels, A Knaeps, J Brugmans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4479779

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  21 in total

Review 1.  Pathogenesis and pharmacology of diarrhea.

Authors:  L Ooms; A Degryse
Journal:  Vet Res Commun       Date:  1986-09       Impact factor: 2.459

2.  Improved measurement of drug exposure in the brain using drug-specific correction for residual blood.

Authors:  Markus Fridén; Helena Ljungqvist; Brian Middleton; Ulf Bredberg; Margareta Hammarlund-Udenaes
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

3.  Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers.

Authors:  Geoffrey Mukwaya; Thomas MacGregor; David Hoelscher; Thomas Heming; Daniel Legg; Kelli Kavanaugh; Phillip Johnson; John P Sabo; Scott McCallister
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

5.  Opiate agonist action of antidiarrheal agents in vitro and in vivo--findings in support for selective action.

Authors:  M Wüster; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

Review 6.  Medical management of fecal incontinence in challenging populations: a review.

Authors:  David Lee; Gaurav Arora
Journal:  Clin Colon Rectal Surg       Date:  2014-09

7.  Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.

Authors:  Tae-Eun Kim; Howard Lee; Kyoung Soo Lim; SeungHwan Lee; Seo-Hyun Yoon; Kyung-Mi Park; Hyesun Han; Sang-Goo Shin; In-Jin Jang; Kyung-Sang Yu; Joo-Youn Cho
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

8.  Disposition and metabolism of [14C]loperamide in rats.

Authors:  H Miyazaki; K Nambu; Y Matsunaga; M Hashimoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

9.  Local inhibition of myoelectrical activity of human colon by loperamide.

Authors:  I Altaparmakov; M Wienbeck
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

Review 10.  Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.